Coeptis Therapeutics, Inc. Proceeds from Other Equity
Coeptis Therapeutics, Inc. reported Proceeds from Other Equity of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2022-11-08
- Coeptis Therapeutics, Inc. proceeds from other equity for the quarter ending 2022-09-30 was -$2.50K, a 100.19% decline year-over-year.
- Coeptis Therapeutics, Inc. proceeds from other equity for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Coeptis Therapeutics, Inc. proceeds from other equity for the quarter ending 2022-03-31 was $2.50K.
- Coeptis Therapeutics, Inc. proceeds from other equity for the quarter ending 2021-12-31 was -$1.38M.
- Coeptis Therapeutics, Inc. proceeds from other equity for fiscal 2021 was $0.00.
- Coeptis Therapeutics, Inc. proceeds from other equity for fiscal 2020 was $0.00.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 9 month | Proceeds from Other Equity 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$2.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.50K derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$1.38M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.50K 10-Q · filed 2022-08-02 | -$1.37M derived: sum of 3 quarters · filed 2022-08-02 | -$80.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $2.50K 10-Q · filed 2022-05-12 | -$1.37M derived: sum of 2 quarters · filed 2022-05-12 | -$80.00K derived: sum of 3 quarters · filed 2022-11-08 | $2.50K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$82.50K derived: sum of 2 quarters · filed 2022-11-08 | $0.00 derived: sum of 3 quarters · filed 2022-11-08 | $0.00 10-K · filed 2022-03-11 |
| 2021-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.38M derived: sum of 2 quarters · filed 2022-11-08 | $1.38M 10-Q · filed 2022-11-08 | $1.28M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $82.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $82.50K 10-Q · filed 2022-08-02 | -$17.50K derived: sum of 3 quarters · filed 2022-08-02 | $82.50K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | -$100.00K derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-05-12 | $0.00 derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $0.00 10-K · filed 2022-03-11 |
| 2020-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $100.00K derived: sum of 2 quarters · filed 2021-11-15 | $100.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q/A · filed 2021-05-18 |